About RECEPTOR.AI
Receptor.AI is committed to pushing the boundaries of precision medicine by developing a pipeline of novel small molecules that possess ultimate selectivity in targeting highly similar disease-related proteins such as homologs, mutants, isoforms, and allele variations.
Our proprietary five-level selectivity assessment engine is designed to laser-focus on protein variants specific to particular human populations, organs, tissues and tumour types, ensuring precise alignment with patient profiles.
Receptor.AI platform combines experimental structure determination techniques and AI-augmented medicinal chemistry, unlocking allosteric and cryptic binding pockets and unravelling protein conformational flexibility, making it possible to discriminate between otherwise indistinguishable targets and off-targets.
|
|
|
11-50 employees
View all RECEPTOR.AI employees
|
|
Biotechnology Research
|
|
London, US
|
|
2021
|
|
Drug Discovery, Bioinformatics, Nlp, Clinical Trials, Artificial Intelligence, Deep Learning, Chemoinformatics, Qsar, Medicinal Chemistry, Drug Repurposing, Target Identification, Reinforcement Learning, Lead Optimisation, Drug Form & Solubility
|
Search RECEPTOR.AI Staff Directory
Find accurate personal emails, work emails and phone numbers for employees
Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut
Find countless prospects outside of LinkedIn fast
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.
